Goldman Sachs Reiterates Conviction Buy Rating on Johnson & Johnson (JNJ)
Tweet Send to a Friend
Goldman Sachs analyst Asad Haider reiterated a Conviction Buy rating and $177.00 price target on Johnson & Johnson (NYSE: JNJ).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
